Sysmex Inostics
Susan Petersen is a highly experienced Senior Quality Assurance Manager at Sysmex Inostics, leading the global QA/RA team to ensure adherence to quality and regulatory compliance for the Quality Management System. With a career spanning over three decades, Susan's expertise includes managing audit programs, IVD kit design and development, risk management, and customer complaint handling. Prior roles at Life Technologies, Medela, EmpiriQA, and Abbott Diagnostics showcase a strong background in regulatory affairs, quality management systems, and compliance auditing. Susan holds an MBA from Lake Forest Graduate School of Management and a B.S. in Biochemistry from the University of Wisconsin-Parkside.
This person is not in any offices
Sysmex Inostics
Leaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD). SafeSEQ NGS technology can detect clinically relevant mutations in circulating tumor DNA (ctDNA) with robust detection as low as 0.03% mutant allele frequency (MAF), thus ensuring reliable molecular information for real-time therapy selection as well as monitoring of tumor response from across a broader range of genomic regions.